ALKS — AI Stock Analysis & Recommendation

TradeFlare's AI research teams rate ALKS a BUY with a conviction of 75/100. The current price is $49.16.

Entry: $41.5682
Target: $47.9
Stop: $37.58

The 52-week breakout suggests potential for sustained upward momentum over the coming weeks. Catalysts to watch: Strong Q1 earnings and revenue beats driving positive sentiment; Successful clinical trial results and positive analyst outlook; Technical indicators showing a strong bullish uptrend continuation. Key risks: Product concentration risk on LYBALVI and VIVITROL; Pipeline dependency for future growth and revenue; High debt-to-equity ratio introduces financial risk.

FlareScore breakdown — Technical: 80 · Fundamental: 75 · Sentiment: 75 · Risk: 30

Frequently asked questions

Is ALKS a buy? TradeFlare's AI currently rates ALKS a BUY with 75/100 conviction.

What is the price target for ALKS? TradeFlare's AI price target for ALKS is $47.9.

Last updated August 27, 2026 · AI-generated analysis for informational purposes, not financial advice.